On-demand webinar: Risk mitigation for single-use cold chain distribution
This webinar shares study data, research experience and best practices to mitigate the risks of single-use bags in the frozen distribution steps.
List view / Grid view
This webinar shares study data, research experience and best practices to mitigate the risks of single-use bags in the frozen distribution steps.
When the pandemic broke out in 2020, pharmaceutical supply chains showed signs of potential failure across the continent. Now, with COVID-19 cases rising once more, and an end to the problem not yet in sight, we discuss with Medicines for Europe how these supply chains are faring, almost two years…
Killian O’Driscoll, Director of Projects at the National Institute for Bioprocessing Research and Training (NIBRT), highlights the plight of a future skills shortage in the global biopharma industry as state-of-the-art therapy production evolves at a rapid pace.
This paper discusses the results of a study that help to mitigate the risks during frozen shipping and ensure consistent product quality in cold chain.
In this application note, we show a successful example of the adaptation of a human recombinant protein-expressing HEK293 cell line.
This whitepaper considers sterility testing to support pharmacopoeial monographs with an emphasis on products that are difficult to test or validate.
This whitepaper provides a roadmap for assessing and selecting the right partner to get promising biological therapies to patients quickly.
Critically examining data management in ADC development and research.
This webinar considers the fundamental importance of water system control within pharma processing and the best control and monitoring practices.
2021 Medicines for Europe-IGBA conference speakers assert that off-patent medicines will be crucial to rebuild healthcare post-COVID-19.
This webinar considers the problems bacterial and fungal spores present for contamination control and remediation and disinfection strategies.
This whitepaper outlines the important components of an environmental monitoring programme, providing practical advice and best practice guidance.
All-in-one Drug Anti-Counterfeit Solution for improved pharma product security and brand protection, brought to big pharma companies via tec5USA.
In this article, EPR's Hannah Balfour outlines six factors that could significantly challenge the generics and biosimilars market in the next decade.
With 16 reactors at 1mL, The Crystal16 enables scientists to determine solubility curves, assess dispersion stability and critical solution temperatures.